The largest database of trusted experimental protocols

9 protocols using sinrf2

1

Transfection of NSCLC cells with siRNAs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ShRNA transfections were performed using the MegaTran 1.0 Transfection Reagent (OriGene) according to the manufacturer’s instructions. The lentiviruses were used to infect NSCLC cells with Polybrene (8 μg/ml) for 4 h. The original medium was replaced with fresh medium 12 h later. The siRNAs, siNrf2, and siNestin, were purchased from Ribobio, and their encoding vectors were transfected into NSCLC cells using the Lipofectamine RNAiMAX Transfection Reagent (Invitrogen).
+ Open protocol
+ Expand
2

Nrf2 Silencing in Chondrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, siRNA negative control (si-Crtl) and its target siRNA Nrf2 (si-Nrf2) by Ribobio (Guangzhou, China) were constructed and synthesized. Then, chondrocytes were seeded in a 6-well plate for 24 h. Transfection with si-Nrf2 or si-NC were carried out using Lipofectamine 2000 reagent according to the protocol.
+ Open protocol
+ Expand
3

Adenoviral Knockdown of CTRP3 in Adipocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adenoviral vectors carrying CTRP3 small hairpin RNAs (shRNAs) designed to knock down CTRP3 in adipocytes were generated by Hanbio (Shanghai, China). Scrambled shRNA was used as a control. Briefly, adipocytes were incubated in DMEM/F12 and were infected with adenoviral vectors at a multiplicity of infection (MOI) of 100 for 4 h. To knock down Nrf2 in H9c2 cells, we purchased siNrf2 and negative-control siRNA from Guangzhou RiboBio Co., Ltd. H9c2 cells were transfected with siNrf2 using Lipofectamine RNAiMAX (Invitrogen) for 24 h. Transfection efficiency was confirmed by western blotting. AntagomiR-200a and a miRNA inhibitor control, which were obtained from Guangzhou RiboBio Co., Ltd, were used to silence miR-200a in H9c2 cells.
+ Open protocol
+ Expand
4

Constructing ALK7-overexpressing Plasmid

Check if the same lab product or an alternative is used in the 5 most similar protocols
The full-length ALK7 cDNA was cloned into the pcDNA3.0 plasmid (Invitrogen Corporation, San Diego, CA, USA) to construct the ALK7-overexpressing plasmid, pcDNA3.0-ALK7. The mammalian expression vector pcDNA3.0 was used as the transfection control. si-ALK7 and si-Nrf2 were obtained from RiboBio Co. Ltd.. HBZY-1 cells were transfected using lipofectamine 2000 (Invitrogen).
+ Open protocol
+ Expand
5

Nrf2 Knockdown in Microglia Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
For transfection, microglia were inoculated at a density of 40–60% and infected with lentivirus at a multiplicity of infection (MOI) of 20. After 12 h of transfection, the medium was changed. Following cell confluence, the transfected microglia were passaged for further experiments. To suppress the expression of Nrf2, microglia (50–60% confluence) were transfected with Nrf2 small interfering RNAs (Si-Nrf2; RiboBio, China, Supplementary Table 3) according to the manufacturer’s protocol. The transfection efficiency was evaluated by western blot analysis.
+ Open protocol
+ Expand
6

Overexpression and Silencing of CTRP3 in HK-2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression plasmids containing CTRP3 cDNA (pcDNA-CTRP3) and negative controls (vector) were constructed by Jennio Biotech (Guangzhou, China). CTRP3 siRNA (siCTRP3) and negative control siRNA (siNC) were designed and synthesized by RiboBio (Guangzhou, China) and transfected to HK-2 cells using Lipofectamine 2000 (Thermo Scientific, Waltham, MA, USA) by following the manufacturer’s instructions. The cells were transfected for 24 h, and then used for further tests after being treated with or without cisplatin for 24 h. The siRNA targeting Nrf2 (siNrf2) and its negative control (siNC) were obtained from RiboBio (Guangzhou, China) and transfected into cells, following the manufacturer’s instructions.
+ Open protocol
+ Expand
7

Knockdown of PINK1, Parkin, Nrf2, and HO-1 in Nucleus Pulposus Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
SiRNAs against PINK1 (siPINK1) (5′‐GCUAGUUACAAGAGAACAA‐3′), Parkin (siParkin) (5′‐GAAUACAUUCCCUACCUCA‐3′), Nrf2 (siNrf2) (5′‐GAGAAAGAAUUGCCUGUAA‐3′), and HO‐1 (siHO‐1) (5′‐CAGUUGCUGUAGGGCUUUA‐3′) and scrambled siRNA (si‐Control) (5′‐UUCUCCGAACGUGUCACGU‐3′) were designed and synthesized by RiboBio. Nucleus pulposus cells were transfected for 48 hours with 100 nmol/L of each siRNA using Lipofectamine® 2000 (Invitrogen) according to the manufacturer's instructions. The cells were then used for experiments.
+ Open protocol
+ Expand
8

Molecular Regulation of NRF2 and NQO1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression plasmids, pENTER-NRF2, pENTER-NQO1, and the pENTER-vector, were obtained from Vigenebio Inc. (MD, USA). The siRNAs (small interfering RNAs), siNQO1, siNRF2, and siNC (negative control), and miRNAs, miR-450b-5p mimic, miR-450b-5p inhibitor, and their respective negative controls, were all purchased from Ribobio Inc. (Guangzhou, China). The plasmids, miRNAs and siRNAs, were transfected alone or co-transfected into cells as mentioned in the result part using Lipofectamine 2000 (Thermo Fisher, CA, USA) according to the manufacturer’s instructions. The sequences of siRNAs and miRNAs were listed in the Supplementary Table S2.
+ Open protocol
+ Expand
9

Chondrocyte Transfection with siNrf2

Check if the same lab product or an alternative is used in the 5 most similar protocols
After reaching 50% confluence, chondrocytes cultured in six-well plates were transfected with siNrf2 and siNC, which were provided by RiboBio (Guangzhou, China), using Lipofectamine 3000 transfection reagent on the base of the instruction for 6 h at 37°C. Transfected cells were used for subsequent experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!